210 related articles for article (PubMed ID: 18985310)
21. A polymorphic CD40 ligand (CD154) molecule mediates CD40-dependent signalling but interferes with the ability of soluble CD40 to functionally block CD154:CD40 interactions.
Barnhart B; Ford GS; Bhushan A; Song C; Covey LR
Immunology; 2000 Jan; 99(1):54-61. PubMed ID: 10651941
[TBL] [Abstract][Full Text] [Related]
22. Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions.
Grammer AC; Slota R; Fischer R; Gur H; Girschick H; Yarboro C; Illei GG; Lipsky PE
J Clin Invest; 2003 Nov; 112(10):1506-20. PubMed ID: 14617752
[TBL] [Abstract][Full Text] [Related]
23. Interaction of CD154 with different receptors and its role in bidirectional signals.
Alturaihi H; Hassan GS; Al-Zoobi L; Salti S; Darif Y; Yacoub D; El Akoum S; Oudghiri M; Merhi Y; Mourad W
Eur J Immunol; 2015 Feb; 45(2):592-602. PubMed ID: 25403978
[TBL] [Abstract][Full Text] [Related]
24. CD40 can costimulate human memory T cells and favors IL-10 secretion.
Rogers NJ; Jackson IM; Jordan WJ; Lombardi G; Delikouras A; Lechler RI
Eur J Immunol; 2003 Apr; 33(4):1094-104. PubMed ID: 12672076
[TBL] [Abstract][Full Text] [Related]
25. Prevention of passively transferred experimental autoimmune myasthenia gravis by a phage library-derived cyclic peptide.
Venkatesh N; Im SH; Balass M; Fuchs S; Katchalski-Katzir E
Proc Natl Acad Sci U S A; 2000 Jan; 97(2):761-6. PubMed ID: 10639153
[TBL] [Abstract][Full Text] [Related]
26. The role of CD80, CD86, and CTLA4 in alloimmune responses and the induction of long-term allograft survival.
Judge TA; Wu Z; Zheng XG; Sharpe AH; Sayegh MH; Turka LA
J Immunol; 1999 Feb; 162(4):1947-51. PubMed ID: 9973463
[TBL] [Abstract][Full Text] [Related]
27. Cross-species costimulation: relative contributions of CD80, CD86, and CD40.
Rogers NJ; Jackson IM; Jordan WJ; Hawadle MA; Dorling A; Lechler RI
Transplantation; 2003 Jun; 75(12):2068-76. PubMed ID: 12829914
[TBL] [Abstract][Full Text] [Related]
28. Complete rejection of a T-cell lymphoma due to synergism of T-cell receptor costimulatory molecules, CD80, CD40L, and CD40.
Ruybal P; Gravisaco MJ; Barcala V; Escalada A; Di Sciullo P; Waldner C; Mongini C
Vaccine; 2008 Jan; 26(5):697-705. PubMed ID: 18155328
[TBL] [Abstract][Full Text] [Related]
29. Targeting of human renal tumor-derived endothelial cells with peptides obtained by phage display.
Bussolati B; Grange C; Tei L; Deregibus MC; Ercolani M; Aime S; Camussi G
J Mol Med (Berl); 2007 Aug; 85(8):897-906. PubMed ID: 17384922
[TBL] [Abstract][Full Text] [Related]
30. Blockade of the CD154-CD40 costimulatory pathway prevents the development of experimental autoimmune glomerulonephritis.
Reynolds J; Khan SB; Allen AR; Benjamin CD; Pusey CD
Kidney Int; 2004 Oct; 66(4):1444-52. PubMed ID: 15458437
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms of CD23 hyperexpression on B cells from patients with rheumatoid arthritis.
De Miguel S; Galocha B; Jover JA; Bañares A; Hernández-García C; García-Asenjo JA; Fernández-Gutiérrez B
J Rheumatol; 2001 Jun; 28(6):1222-8. PubMed ID: 11409113
[TBL] [Abstract][Full Text] [Related]
32. Identification of three novel peptides that inhibit CD40-CD154 interaction.
Kitagawa M; Goto D; Mamura M; Matsumoto I; Ito S; Tsutsumi A; Sumida T
Mod Rheumatol; 2005; 15(6):423-6. PubMed ID: 17029106
[TBL] [Abstract][Full Text] [Related]
33. Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis.
Binétruy-Tournaire R; Demangel C; Malavaud B; Vassy R; Rouyre S; Kraemer M; Plouët J; Derbin C; Perret G; Mazié JC
EMBO J; 2000 Apr; 19(7):1525-33. PubMed ID: 10747021
[TBL] [Abstract][Full Text] [Related]
34. Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer.
Tong AW; Papayoti MH; Netto G; Armstrong DT; Ordonez G; Lawson JM; Stone MJ
Clin Cancer Res; 2001 Mar; 7(3):691-703. PubMed ID: 11297266
[TBL] [Abstract][Full Text] [Related]
35. RNAi-mediated silencing of CD40 prevents leukocyte adhesion on CD154-activated endothelial cells.
Pluvinet R; Pétriz J; Torras J; Herrero-Fresneda I; Cruzado JM; Grinyó JM; Aran JM
Blood; 2004 Dec; 104(12):3642-6. PubMed ID: 15315968
[TBL] [Abstract][Full Text] [Related]
36. Central role for CD40/CD40 ligand (CD154) interactions in transplant rejection.
Denton MD; Reul RM; Dharnidharka VR; Fang JC; Ganz P; Briscoe DM
Pediatr Transplant; 1998 Feb; 2(1):6-15. PubMed ID: 10084754
[TBL] [Abstract][Full Text] [Related]
37. A humanized anti-human CD154 monoclonal antibody blocks CD154-CD40 mediated human B cell activation.
Brams P; Black A; Padlan EA; Hariharan K; Leonard J; Chambers-Slater K; Noelle RJ; Newman R
Int Immunopharmacol; 2001 Feb; 1(2):277-94. PubMed ID: 11360929
[TBL] [Abstract][Full Text] [Related]
38. CD40, CD80, and CD86 costimulatory molecules are differentially expressed on murine splenic antigen-presenting cells during the pre-implantation period of pregnancy, and they modulate regulatory T-cell abundance, peripheral cytokine response, and pregnancy outcome.
Slawek A; Maj T; Chelmonska-Soyta A
Am J Reprod Immunol; 2013 Aug; 70(2):116-26. PubMed ID: 23445188
[TBL] [Abstract][Full Text] [Related]
39. Regulatory T cells modulate postischemic neovascularization.
Zouggari Y; Ait-Oufella H; Waeckel L; Vilar J; Loinard C; Cochain C; Récalde A; Duriez M; Levy BI; Lutgens E; Mallat Z; Silvestre JS
Circulation; 2009 Oct; 120(14):1415-25. PubMed ID: 19770391
[TBL] [Abstract][Full Text] [Related]
40. Anergic cells induced by the blockade of CD40-CD154 and CD28-B7 costimulatory pathways act as potent immunoregulatory cells in vitro and vivo.
Cai Y; Zhou PJ; Tang XD
Chin Med J (Engl); 2004 Aug; 117(8):1178-83. PubMed ID: 15361291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
